Cogent Biosciences Announces Submission of New Drug Cogent Biosciences, Inc., a biotechnology company focused on precision therapies for genetically defined diseases, announced today that it has submitted its New Drug submission to the relevant regulatory authorities. This milestone marks a key phase in the company’s effort to bring targeted, mechanism-based treatments to patients who currently…